Global PDX models market is projected to register a healthy CAGR of 16.6% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation:
Global PDX Models Market, By Type (Mice Models and Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models and Others), Application (Preclinical Drug Development, Precision Medicine, Co-clinical Trials, Basic Cancer Research & Biomarker Analysis), Technique (Heterotopic Implantation and Orthotropic Implantation), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Organizations and Others), Country (U.S., Canada, Mexico, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the global PDX models market are:

• Wide adoption of PDX models in preclinical research
• Increase in demand of personalized medicine
• Strategic initiative by government and private organizations

Market Players:

The key market players for global PDX models market are listed below:

• Crown Bioscience Inc.
• THE JACKSON LABORATORY
• Champions Oncology, Inc.
• Charles River Laboratories
• Wuxi AppTec
• Oncodesign
• Aragen Bioscience
• Biocytogen
• Bioduro
• BioModels
• Creative Animodel
• Covance Inc.
• EPO Berlin-Buch GmbH
• EUROPDX.
• Explora Biolabs
• Hera BioLabs
• Horizon discovery Ltd.
• Pharmatest Services
• Urosphere SAS
• Xentech
• Xenopat